TAREG 3 mg/ml, oral solution bottle, 160 ml
Active ingredients: Valsartan
Commercialized according to BDPMDispensing in France: Prescription only
Oral solutionbottle, 160 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TAREG 3 mg/ml, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- flacon(s) en verre de 160 ml avec fermeture de sécurité enfant avec seringue(s) pour administration orale polypropylène avec gobelet(s) doseur(s) polypropylène
- Marketing authorisation holder
- NOVARTIS PHARMA
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Hypertension chez les enfants de 1 à 18 ans ; JOURNAL OFFICIEL ; 23/08/11
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 28 Sept 2011
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62518793CIP74914748CIP133400949147489Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VALSARTANsolution | 3 mg · 1 ml de solution buvable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.